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Abstract. 
 
Antigen-evoked inﬂux of extracellular Ca
 
2
 
1
 
 
into mast cells may occur via store-operated Ca
 
2
 
1 
 
chan-
nels called calcium release–activated calcium (CRAC) 
 
channels. In mast cells of the rat basophilic leukemia cell 
line (RBL-2H3), cholera toxin (CT) potentiates anti-
gen-driven uptake of 
 
45
 
Ca
 
2
 
1
 
 through cAMP-indepen-
dent means. Here, we have used perforated patch 
clamp recording at physiological temperature to test 
whether cholera toxin or its substrate, Gs, directly mod-
ulates the activity of CRAC channels. Cholera toxin 
dramatically ampliﬁed (two- to fourfold) the Ca
 
2
 
1
 
 re-
 
lease–activated Ca
 
2
 
1
 
 current (I
 
CRAC
 
) elicited by subop-
timal concentrations of antigen, without itself inducing 
I
 
CRAC
 
, and this enhancement was not mimicked by 
cAMP elevation. In contrast, cholera toxin did not af-
fect the induction of I
 
CRAC
 
 by thapsigargin, an inhibitor 
of organelle Ca
 
2
 
1
 
 pumps, or by intracellular dialysis 
with low Ca
 
2
 
1
 
 pipette solutions. Thus, the activity of 
CRAC channels is not directly controlled by cholera 
 
toxin or Gs
 
a
 
.
 
 Nor was the potentiation of I
 
CRAC
 
 due to 
enhancement of phosphoinositide hydrolysis or calcium 
release. Because Gs and the A subunit of cholera toxin 
 
bind to ADP ribosylation factor (ARF) and could 
modulate its activity, we tested the sensitivity of anti-
gen-evoked I
 
CRAC
 
 to brefeldin A, an inhibitor of ARF-
dependent functions, including vesicle transport. 
Brefeldin A blocked the enhancement of antigen-
evoked I
 
CRAC
 
 without inhibiting ADP ribosylation of 
Gs
 
a
 
, but it did not affect I
 
CRAC
 
 induced by suboptimal 
antigen or by thapsigargin. These data provide new evi-
dence that CRAC channels are a major route for Fc
 
e
 
 
receptor I–triggered Ca
 
2
 
1
 
 inﬂux, and they suggest that 
ARF may modulate the induction of I
 
CRAC
 
 by antigen.
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2
 
1
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Introduction
 
Calcium influx is thought to be required for the secretion
of inflammatory mediators, activation of transcription fac-
tors, and the elaboration of cytokines by rat mast cells
stimulated through the high affinity receptor (Fc
 
e
 
RI) for
IgE. Cholera toxin (CT)
 
1
 
 markedly potentiates Fc
 
e
 
RI-
mediated uptake of 
 
45
 
Ca
 
2
 
1
 
 (Narasimhan et al., 1988) and
secretion of preformed mediators (McCloskey, 1988;
Narasimhan et al., 1988) by rat basophilic leukemia cell
line (RBL-2H3) mast cells. The mechanisms by which
Ca
 
2
 
1
 
 uptake and secretion are enhanced remain unknown.
It is possible that the CT substrate, Gs, regulates Ca
 
2
 
1
 
 en-
try by direct interaction with the presumed Fc
 
e
 
RI-acti-
vated Ca
 
2
 
1
 
 channel, as is thought to occur with voltage-
gated Ca
 
2
 
1
 
 channels in skeletal muscle (Hamilton et al.,
1991). CT also might act indirectly by enhancing the driv-
ing force on Ca
 
2
 
1
 
 influx via membrane hyperpolarization.
Here, we test these hypotheses using perforated patch
clamp recording at physiological temperature from intact
RBL-2H3 cells (Zhang and McCloskey, 1995).
Experiments using radiotracer flux, Ca
 
2
 
1
 
-sensing fluo-
rescent dyes, and patch clamping suggest that Fc
 
e
 
RI-medi-
ated Ca
 
2
 
1
 
 influx in RBL-2H3 mast cells may occur largely
by so-called store-operated or capacitative calcium entry
(Ali et al., 1994; McCloskey, 1999). According to this
scheme, conceived by James Putney to account for inosi-
tol trisphosphate (InsP
 
3
 
)-induced Ca
 
2
 
1
 
 influx in exocrine
cells, depletion of lumenal Ca
 
2
 
1
 
 from the ER activates a
Ca
 
2
 
1
 
 entry pathway in the plasma membrane (Putney,
1986, 1990). Calcium currents associated with this pathway
were first observed in Jurkat human T cells and rat perito-
neal mast cells, in which they are called Ca
 
2
 
1
 
 release–acti-
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vated calcium currents, or I
 
CRAC
 
 (Lewis and Cahalan,
1989; Hoth and Penner, 1992; Zweifach and Lewis, 1993).
Ca
 
2
 
1
 
 store depletion is now known to elicit Ca
 
2
 
1
 
 influx
currents superficially related to I
 
CRAC
 
 in a variety of cell
types (for reviews see Fasolato et al., 1994; Berridge, 1995;
Fanger et al., 1995).
The mechanism that links Ca
 
2
 
1
 
 store depletion to Ca
 
2
 
1
 
influx via calcium release–activated calcium (CRAC) chan-
nels has yet to be determined, and we do not address this
issue here. A separate, unanswered question is whether
I
 
CRAC
 
 
 
can be elicited or amplified through means other
than Ca
 
2
 
1
 
 store depletion. That CT enhances antigen-
evoked 
 
45
 
Ca
 
2
 
1
 
 uptake into RBL-2H3 cells might suggest a
role for the toxin substrate, Gs, in regulation of store-oper-
ated Ca
 
2
 
1
 
 influx. This trimeric GTP-binding protein regu-
lates Ca
 
2
 
1
 
 transport in a number of different systems,
through means in addition to cAMP-dependent phosphor-
ylation. In skeletal and cardiac muscle cells, for example,
direct binding of Gs
 
a
 
-GTP to voltage-gated Ca
 
2
 
1
 
 channels
is thought to increase the channel’s open probability (Ya-
tani et al., 1987; Hamilton et al., 1991). Several other find-
ings point to a more general involvement of Gs in cAMP-
independent regulation of Ca
 
2
 
1
 
 and/or Mg
 
2
 
1
 
 transport
across the plasma membrane (Maguire and Erdos, 1980;
Murphy and McDermott, 1992; Scamps et al., 1992; Jou-
neaux et al., 1993). With this precedent, it is relevant to ask
whether the potentiation of antigen-evoked 
 
45
 
Ca
 
2
 
1
 
 influx
by CT involves direct modulation of presumed CRAC
channels by the toxin or its substrate, Gs
 
a
 
.
We found that CT markedly enhanced Fc
 
e
 
RI-induced
Ca
 
2
 
1
 
 currents in RBL-2H3 cells by a mechanism that is
largely independent of cAMP. CT did not affect the induc-
tion of I
 
CRAC
 
 by Ca
 
2
 
1
 
 store depletion, per se. The enhance-
ment of antigen-evoked I
 
CRAC
 
 was not an indirect effect of
membrane hyperpolarization, nor was it a direct effect of
the toxin or Gs on CRAC channel properties. Rather, CT
appeared to potentiate I
 
CRAC
 
 by modulating an upstream
signal other than phosphoinositide hydrolysis or Ca
 
2
 
1
 
 re-
lease. The brefeldin A (BFA)-sensitivity of this step sug-
gests the involvement of an ADP ribosylation factor
(ARF) in the induction of I
 
CRAC
 
 via the Fc
 
e
 
RI.
 
Materials and Methods
 
Reagents
 
Cholera holotoxin was from List Biological Laboratories. S-p-adenosine-
3
 
9
 
,5
 
9
 
-cyclic monophosphorothioate (Sp-cAMPS) was from Biomol Re-
search Laboratories, Inc. BFA, EGTA, dibutyryl adenosine-3
 
9
 
,5
 
9
 
-cyclic
monophosphate, methylsulfoxide, nystatin, probenecid, and thapsigar-
gin were from Sigma Chemical Co. Myo-[2
 
3
 
H]inositol (18 Ci/mmol)
was  from Amersham Life Sciences. 1,2-bis-(2-aminophenoxy)ethane-
 
N,N,N
 
9
 
,N
 
9
 
-tetraacetic acid (BAPTA) free acid was from Molecular
Probes. BFA was used at a final concentration of 2 
 
m
 
g/ml, obtained by di-
luting 1,000-fold into growth medium a 2-mg/ml stock solution in methyl-
sulfoxide. Thapsigargin was diluted 500-fold into external buffer (see be-
low) from methylsulfoxide stock solutions of appropriate thapsigargin
concentration. Nystatin stock solutions (50 mg/ml) in methylsulfoxide
were made fresh each day. All tissue culture reagents were from GIBCO
BRL. Trinitrophenylated BSA (TNP-BSA) containing 
 
z
 
15 mol TNP per
mol BSA was synthesized as described (McCloskey, 1993).
 
Cell Culture
 
The rat basophilic leukemia (RBL-2H3) cell line (Barsumian et al., 1981)
was obtained from Dr. Reuben Siraganian (National Institutes of Health,
Bethesda, MD) and grown for up to 30 passages before starting fresh cul-
tures from frozen cell suspensions. Monolayer cultures were maintained at
37
 
8
 
C, 5% CO
 
2
 
 in MEM (Earle’s salts) containing 15% heat-inactivated
FBS, 100 U/ml penicillin, and 100 
 
m
 
g/ml streptomycin sulfate. Stock cul-
tures were passaged by trypsinization at 4-d intervals. In two sets of exper-
iments, Ca
 
2
 
1
 
 currents were measured in RBL-2H3 cells obtained from the
American Type Culture Collection. Ca
 
2
 
1
 
 currents in these cells were
larger than others measured in this study, whether measured at 5- or the
usual 4-d postpassage. Cells harvested from stock cultures were seeded
onto 12-mm round glass coverslips contained in 24-well plates (8 
 
3
 
 10
 
4
 
cells/well) and grown for 12–18 h in medium containing IgE before patch
clamping. Monoclonal anti-TNP IgE, IGEL a2, (Rudolph et al., 1981)
(TIB 142; American Type Culture Collection) partially purified from as-
cites was added to the culture medium at a protein concentration of 12 
 
m
 
g/
ml. Just before the experiment, coverslips were rinsed in normal Ringer
(see below) and placed into a recording chamber.
 
Electrical Recording
 
Except where noted otherwise, all experiments were conducted on intact
cells using nystatin perforated patch recording (Horn and Marty, 1988).
Methods used for conventional and perforated patch whole cell recording
were as described previously (Fan and McCloskey, 1994; Zhang and Mc-
Closkey, 1995). Nystatin was used at a final concentration of 250 
 
m
 
g/ml,
produced by a 200-fold dilution of a 50-mg/ml solution (in methylsufulfox-
ide) into pipette solution. All experiments were conducted at 37
 
8
 
C, using a
Peltier device to warm the sample (Medical Systems Corp.). For most ex-
periments, cells were voltage-clamped at a holding potential of 0 mV, and
voltage ramp stimuli (
 
2
 
100 to 
 
1
 
50 mV, 0.64 mV/ms) applied at 10-s inter-
vals. A 140-ms conditioning pulse to 
 
2
 
100 mV was applied before each
ramp, in part to prevent rapid inactivation during the ramp from distort-
ing the shape of the current-voltage (
 
I-V
 
) curve (Zhang and McCloskey,
1995). The Ca
 
2
 
1
 
 current induced by antigen during perforated patch re-
cording decays more rapidly than does that elicited by thapsigargin or by
high concentrations of intracellular BAPTA; hereafter, I
 
Ca
 
 refers to the
peak Ca
 
2
 
1
 
 current measured at 
 
2
 
80 mV. Micropipettes were pulled from
Accu-fill 90 Micropets (B-D) and heat polished to resistances of 2–4 M
 
V
when filled with cesium glutamate (see below).
Conductances induced by antigen or thapsigargin were determined by
computer subtraction of average traces acquired before from those taken
after induction of inward Ca21 currents. This method was verified on a
few cells by Ca21 removal, which eliminated the inward current in stan-
dard tetraethylammonium (TEA) aspartate (see below). Due to the ra-
pidity of induction by cytoplasmic BAPTA, I-V plots in these experiments
were determined by subtraction of traces in 0 mM extracellular Ca21 from
those taken in 10 mM extracellular Ca21.
The experimental averages include cells from experiments conducted
on multiple days. To minimize systematic errors, on each day we assayed
at least three control cells and three cells from each treatment, where up
to three treatments were carried out each day. All experimental values in
this paper are presented as the average 6 SEM, and statistical significance
was determined using the t test. Differences were considered significant if
P , 0.05, and all differences listed were significant unless stated other-
wise.
Solutions Used for Electrical Recording
For perforated patch recording, the pipette solution contained 55 mM
KCl, 70 mM K2SO4, 7 mM MgCl2, 5 mM glucose, and 10 mM Hepes, pH
7.35. The Cs glutamate pipette solution used for conventional whole cell
recording contained 150 mM glutamic acid, 8 mM NaCl, 10 mM BAPTA
(H1)4, 2.0 mM CaCl2, 1.0 mM MgCl2, 0.5 mM MgATP, and 10 mM Hepes
titrated to pH 7.20 with CsOH; the estimated free Ca21 concentration in
this solution was z30 nM. The standard bath solution was TEA aspartate,
which contained 10 mM CaCl2, 1 mM MgCl2, 88 mM NaOH, 152.5 mM as-
partic acid, 64.5 mM tetraethylammonium hydroxide, 5.6 mM glucose, and
5 mM Hepes titrated to pH 7.4 with TEA hydroxide. This composition
was chosen to eliminate outward Cl2 and inward K1 currents, and to an-
tagonize outward K1 currents with tetraethylammonium ion. The zero
Ca21 external buffer was Ca21-free TEA aspartate containing 1 mM
EGTA as well as 15 mM N-methyl-D-glucamine aspartate in place of
CaCl2. The solution used for Ba21 substitution contained 10 mM Ba21 in
place of Ca21, and 1 mM EGTA was present to chelate Ca21 remaining af-
ter solution exchange.McCloskey and Zhang Cholera Toxin-enhanced Ca21 Current in Mast Cells 139
[32P]ADP Ribosylation
ADP ribosylation was carried out as described previously (McCloskey,
1988), except that reactions were terminated by addition of 1 ml ice cold
10 mM Hepes, pH 7.3, 135 mM NaCl and the membranes pelleted by cen-
trifugation for 10 min at 20,000 g. Radioactive bands in the dried gels were
imaged and digitized using a PhosphorImager, the image labeled in
Adobe Photoshop, and printed by photomechanical transfer.
[3H]inositol Phosphates Production
Antigen-stimulated production of inositol phosphates was assayed on cell
monolayers as described previously (Beaven et al., 1984), with the follow-
ing modifications. Cells were grown in three dram glass shell vials for 16–
24 h before assay. Each vial was seeded with 2 3 105 cells in 0.5 ml me-
dium containing 1.5 mg/ml anti-TNP IgE and 2 mCi/ml myo-[3H]inositol
(18 Ci/mmol). The growth medium was as described above but containing
1 rather than 15% FBS.
Calcium Imaging
Digital imaging of fura-2 loaded mast cells was carried out essentially as
described for J774 monocytes (Fan and McCloskey, 1994), except that
cells were imaged at 33–348C rather than room temperature. Cells were
cultured overnight under the same conditions used for setting up the patch
clamp experiments, loaded with 1 mM fura-2 AM for 30 min at 378C,
rinsed, and incubated for another 30 min at 378C before imaging in a
Ca21-free external buffer containing 135 mM NaCl, 5 mM KCl, 2 mM
MgCl2, 5.6 mM glucose, 2.5 mM probenecid, 1 mM EGTA, and 10 mM
Hepes, pH 7.4. The Ca21 signal from individual RBL-2H3 cells exhibits
variable lag phases after antigen addition (Millard et al., 1988). To elimi-
nate this variability analytically, we used an Excel program which detects
the first time point at which F340/F380 crosses an arbitrarily set threshold, in
this series of experiments defined as two SDs above the average resting
F340/F380 before antigen addition. These points were then aligned for each
cell and the average time course of F340/F380 calculated for the cells within
the field of view.
Results
Enhancement of Antigen-induced Inward Current
by CT
As observed previously (Zhang and McCloskey, 1995), ad-
dition of 50 ng/ml TNP-BSA to anti-TNP IgE-sensitized
cells induced an inwardly rectifying current with a time-to-
peak of 124 6 70 s (z131 6 9 s in the previous study). De-
crease in antigen concentration lengthened the induction,
the time-to-peak being z200 s at 5 ng/ml and 255 s at 1 ng/ml
TNP-BSA. After reaching a peak, the current normally
decayed substantially within several minutes, this presum-
ably reflecting in part the refilling of intracellular Ca21
stores (Zweifach and Lewis, 1995). Fig. 1 A shows a series
of I-V curves for the inward current induced by different
concentrations of antigen. Each curve represents the aver-
age of measurements on multiple cells (see legend). Fig. 1
B gives the peak inward current measured at 280 mV as a
function of antigen concentration. A graded increase in
magnitude of the induced current was observed up to con-
centrations of TNP-BSA z500 ng/ml, above which the re-
sponse was saturated. At 50 ng/ml, TNP-BSA induced a
peak current at 280 mV of 219.1 6 2.8 pA (n 5 16), simi-
lar to the value of ICa induced by 50 ng/ml TNP-BSA in a
previous study (225.7 6 4.7 pA) that employed the same
antibody–antigen combination (IGEL a2 anti-TNP IgE
and TNP15-BSA).
As indicated in Fig. 1 B, pretreatment of RBL-2H3 cells
with cholera holotoxin potentiated the inward current in-
duced by subsequent exposure to antigen. In these experi-
ments CT was applied at a concentration (2 mg/ml) and for
a time (1.5–2.5 h) shown previously to maximally enhance
antigen-elicited 45Ca21 uptake and secretion by RBL-2H3
cells (McCloskey, 1988; Narasimhan et al., 1988). Potentia-
tion of the inward current was dependent upon antigen
concentration, being quite strong at low antigen concen-
tration and insignificant at an antigen concentration suffi-
cient to saturate the induction. At a concentration of 1 ng/ml,
Figure 1. Effect of antigen concentration on magnitude of peak
calcium current, and potentiation of Ca21 current by CT. During
perforated patch recording at 378C, voltage ramps were applied
from 2100 to 150 mV every 5 s after the onset of induction of ICa
by antigen. For each antigen concentration, the I-V curves re-
corded at the height of induction were averaged over multiple
cells. (A) Average I-V curves obtained at four different concen-
trations of TNP-BSA. Numbers to left of traces indicate TNP-
BSA in ng/ml. The number of cells included in average was 12,
44, 13, and 10 for concentrations of antigen of 1, 5, 50, and 500 ng/ml,
respectively. For clarity, error bars not shown. (B) Plot of antigen
concentration-response for induction of Ca21 current. Peak cur-
rent was measured at 280 mV from individual I-V curves ob-
tained at different antigen concentrations. Numbers inside bars
give sample size (number of cells). Black, control cells; gray, cells
pretreated for 2 h with 2 mg/ml cholera holotoxin. Error bars rep-
resent SEM.The Journal of Cell Biology, Volume 148, 2000 140
control cells exhibited an average current at 280 mV of
z29 pA, and CT pretreatment nearly tripled this to a
value of z224 pA, when all measurements are lumped in
the averages. Table I summarizes the results of paired ex-
periments conducted on different days (n 5 2–23), where
the enhancement each day was calculated from the aver-
age of three to six control and three to six CT-treated cells.
Note that CT enhanced by nearly threefold the inward
current induced by 1 ng/ml TNP-BSA, whereas the current
induced by TNP-BSA at 500 ng/ml was not enhanced by
CT. From these observations it appears that CT might am-
plify a step in the normal induction process that operates
with submaximal efficiency at concentrations of TNP-BSA
,500 ng/ml. Between 50 and 500 ng/ml TNP-BSA, this
step has reached maximal efficiency, and potentiation by
CT is not observed.
Properties of CT-enhanced Ca21 Current
The ionic current elicited by antigen in CT-treated cells
shared several features with that induced by antigen in
control cells. For the sake of comparison, in Fig. 2 A we
show average I-V plots obtained from 12 control and 8
CT-treated cells, each stimulated with 1 ng/ml TNP-BSA.
Fig. 2 B gives average I-V plots obtained from 45 control
and 33 CT-treated cells stimulated with 5 ng/ml TNP-BSA.
The first point of similarity between the control and CT-
enhanced currents is that the shape of their I-V curves was
inwardly rectifying. In both cases the induced current had
a highly positive reversal potential consistent with Ca21 se-
lectivity, and in fact Ca21 is the only major permeant ion
present in the TEA aspartate bath solution with such a
high reversal potential. Moreover, removal of Ca21 from
the bath eliminated the inward current induced by antigen
(data not shown). Fig. 3 A shows the result of an ion sub-
stitution experiment carried out on a CT-treated cell. Note
that the antigen-induced current was carried effectively by
barium ions, and that the shape of the Ba21 I-V plot was
more steeply rectifying than the Ca21 I-V plot. This behav-
ior was demonstrated previously for ICRAC in RBL-2H3
cells, whether ICRAC was elicited by antigen (Zhang and
McCloskey, 1995) or induced by intracellular dialysis with
a solution buffered at very low free Ca21 (Hoth, 1995). To-
gether, these observations suggest that CT amplifies the
same Ca21 current (ICRAC) as that activated by antigen
alone.
The Ca21 current through CRAC channels inactivates
on two different time scales. Rapid but partial inactivation
occurs after step changes of membrane potential from 0
mV to hyperpolarized voltages (Hoth and Penner, 1993;
Zhang and McCloskey, 1995). Recovery from such volt-
age-dependent inactivation is complete within 2 s or less of
returning the potential to 0 mV. Fig. 3 B shows average
traces of normalized membrane current obtained from
three control and three CT-pretreated cells, in each of
which the Ca21 current was induced by 5 ng/ml TNP-BSA.
In control cells, the Ca21 current inactivated by 56 6 6%
(n 5 3) within 100 ms of step hyperpolarization from 0 to
2100 mV. This level of steady-state inactivation is essen-
tially equal to that reported for the Ca21 current induced
by 50 ng/ml TNP-BSA, i.e., a 10-fold higher level of anti-
gen (Zhang and McCloskey, 1995). The antigen-induced
current inactivated to a similar extent (62 6 6%; n 5 3) in
Table I. Cholera Toxin Enhances Antigen-induced ICRAC
TNP-BSA
Enhancement factor*
Range Mean‡
ng/ml
1 1.9–3.8 2.8 6 0.4 (n 5 5)
5 1.2–3.3 2.2 6 0.1 (n 5 23)
50 0.6–2.6 1.5 6 0.3 (n 5 6)
500 1.1 1.1 (n 5 2)
*Since ICRAC varied significantly in different batches of cells, the CT enhancement of
ICRAC in control and CT-treated cells was compared on a day-by-day basis. Enhance-
ment factor was calculated from results of paired experiments where antigen-induced
Ca21 current (at 280 mV) was measured in three to six control and three to six CT-
treated cells each day.
‡Mean enhancement 6 SEM of experiments conducted on n different days.
Figure 2. Average I-V curves for antigen-induced Ca21 current in
control and CT-treated cells obtained during perforated patch re-
cording at 378C. (A) TNP-BSA 5 1 ng/ml. Average plots include
12 control and 8 CT-treated cells. (B) TNP-BSA 5 5 ng/ml. n 5
45 control and 33 CT-treated cells. Note similarity of I-V plots in
control and CT-treated cells, including the highly positive rever-
sal potential.McCloskey and Zhang Cholera Toxin-enhanced Ca21 Current in Mast Cells 141
CT-treated cells, a further point of similarity between the
control and CT-enhanced Ca21 currents. Moreover, this
demonstrates that the enhancement of ICa by CT was not
due to reduced voltage-dependent inactivation. That is,
because ICa was measured from I-V plots obtained by
ramp stimulation after a 140-ms conditioning pulse to
2100 mV, if the extent of inactivation during this prepulse
was less in CT-treated than in control cells, then the value
of ICa would be greater in the CT-treated than in control
cells. Clearly, the potentiation of ICa by CT was not due to
diminished voltage-dependent inactivation in CT-treated
cells.
In principle, the magnitude of the peak Ca21 current
might reflect a balance between rates of activation and
slow inactivation (Zweifach and Lewis, 1995). If so, CT
could increase the peak ICa by enhancing the rate of acti-
vation or reducing the rate of slow inactivation. But an in-
creased rate of activation or a decreased rate of inactiva-
tion should reduce the average time-to-peak. The average
time-to-peak was about the same in control and CT-
treated cells. For example, at 5 ng/ml of TNP-BSA the av-
erage time-to-peak was 205 6 29 s (n 5 27) in control and
238 6 24 s (n 5 25) in CT-treated cells, an insignificant dif-
ference. That CT did not reduce the time-to-peak suggests
that alteration of activation or inactivation rates does not
cause the marked enhancement of ICa.
We can also exclude the possibility that the large en-
hancement of Ca21 influx currents by CT resulted from
the induction of ICa by CT itself. As noted in Materials and
Methods, the I-V curves shown in Figs. 2 and 3, as well as
others used to derive the data shown in Fig. 1 and Table I,
were obtained by computer subtraction of averaged traces
taken before antigen addition. Thus, the measured cur-
rents did not contain any contribution from ICa that might
have been induced by pretreatment with CT alone. It is
still relevant to ask whether CT treatment, per se, induced
ICa. If it did, then by the time electrical recording was be-
gun, the magnitude of any induced Ca21 current was mi-
nuscule, much smaller than the extra z15 pA of current
observed at 1 or 5 ng/ml TNP-BSA (Fig. 1 and Table I).
Thus, a difference I-V plot of average ramp currents ob-
tained from 35 control cells subtracted from 20 CT-treated
cells—all recorded before exposure to antigen—was linear
through the origin (data not shown). The slope reflects a
very small increase in nonspecific leak conductance in the
CT-treated cells (,1 pA at 280 mV), rather than the in-
duction of ICRAC by CT. The large enhancement of anti-
gen-induced ICa by CT was not caused by antigen-indepen-
dent induction.
Induction of ICa Is Not Enhanced by Elevation of cAMP
CT elevates cAMP levels in RBL-2H3 cells (McCloskey,
1988; Narasimhan et al., 1988), presumably through ADP
ribosylation of Gs and activation of adenylyl cylcase. If the
enhancement of ICa by CT is due to chronic elevation of
cAMP, then cell-permeant cAMP mimetics should repro-
duce the effect of the toxin. To test this idea, cells were
preincubated for 1.5–3 h with the cell-permeant and phos-
phatase-resistant cAMP analogue, Sp-cAMPS (100 mM),
and then permeabilized and subjected to voltage-clamp re-
cording in the presence of this compound. Treatment with
Sp-cAMPS caused a modest but statistically insignificant
increase in antigen-elicited inward Ca21 current, consider-
ably less than the enhancement caused by CT in the same
experiments. The average Ca21 current elicited by 5 ng/ml
TNP-BSA was 214.0 6 1.6 pA in control cells (n 5 18),
and 219.9 6 2.5 pA in cells treated with Sp-cAMPS (n 5
Figure 3. CT-enhanced current has I-V characteristics, ionic se-
lectivity, and rapid inactivation typical of ICRAC. (A) Ion substitu-
tion experiment on CT-treated cell in which inward current was
evoked by TNP-BSA. Upper trace is preinduction current, and
lower traces were recorded in 10 mM Ca21 or 10 mM Ba21 (plus
1 mM EGTA and no added Ca21). Note that Ba21 permeates
the CT-sensitive pathway and the Ba21 current rectifies more
strongly than does Ca21 current, as previously shown for antigen-
induced ICRAC in control cells (Zhang and McCloskey, 1995). (B)
Antigen-induced Ca21 current undergoes rapid inactivation to
similar degrees in control and CT-treated cells. After induction
of Ca21 current by TNP-BSA (5 ng/ml), voltage steps to 2100 mV
were applied from the holding potential of 0 mV. Average traces
for three control and three CT-treated cells are shown. Steady-
state inactivation at 100 ms was 56 6 6% in control, and 62 6 6%
in CT-treated cells, an insignificant difference. Perforated-patch
recording at 378C for both A and B.The Journal of Cell Biology, Volume 148, 2000 142
18). In these experiments, CT potentiated antigen-induced
ICa by 2.3-fold. We also tested the effect of another cell-
permeant analogue of cAMP, dibutyryl cAMP, which at a
concentration of 0.5 mM causes modest potentiation of an-
tigen-induced secretion in RBL-2H3 cells (McCloskey,
1988). Dibutyryl cAMP at this concentration had no statis-
tically significant effect on antigen-induced ICa. Thus,
chronic elevation of cAMP does not mimic the enhance-
ment of ICa by CT. Although it is conceivable that CT
could amplify a cAMP transient induced by antigen bind-
ing, and in this way affect ICa, previous studies have shown
that cross-linkage of the FceRI does not elevate cAMP in
RBL-2H3 cells (Morita and Siraganian, 1981), and pre-
treatment with CT does not unmask a latent rise in cAMP
(McCloskey, 1988). Thus, although elevation of cAMP
may contribute, it is not the major factor in the large en-
hancement of antigen-elicted ICa by CT.
CT Does Not Potentiate ICa Induced by Thapsigargin
or BAPTA
The macroscopic Ca21 current, ICa, is directly proportional
to the number of Ca21 channels in the plasma membrane,
their unitary conductance, and their probability of being
open. Previous findings suggest that in RBL-2H3 cells, the
Ca21 currents associated with both antigen- and thapsigar-
gin-induced Ca21 influx (Ali et al., 1994) are carried by the
same Ca21 channel (Zhang and McCloskey, 1995). Thus, if
CT were to increase the open probability or unitary con-
ductance of this species, it should potentiate the macro-
scopic Ca21 current induced by suboptimal concentrations
of thapsigargin, as it does for the antigen-induced current.
As demonstrated in Fig. 4, thapsigargin at 50 pM induced
ICRAC equivalent to that induced by suboptimal antigen (1
ng/ml TNP-BSA). Whereas CT enhanced the antigen-
induced current by z2.2-fold at 1 ng/ml TNP-BSA, it did
not affect the current induced by 50 pM thapsigargin. In-
deed, CT did not significantly affect the Ca21 currents in-
duced by thapsigargin at any concentration tested. This
suggests that neither CT nor its substrate Gs, modifies the
unitary conductance or open probability of CRAC chan-
nels in RBL-2H3 cells.
Thapsigargin presumably activates ICRAC by inhibiting
the Ca21 pumps of the ER (Thastrup et al., 1990) and al-
lowing passive leak of stored Ca21 into the cytosol. In mast
cells, ICRAC can also be induced by dialysis of the cell cyto-
plasm with low Ca21 pipette solutions buffered with high
concentrations of the calcium chelator BAPTA (Fasolato
et al., 1993), conditions which prevent re-uptake of Ca21
by the ER. We tested the effect of CT on ICRAC induced by
dialysis with BAPTA. Cells were preincubated with 2 mg/ml
CT for 1.5–3 h, then standard whole cell recording was
performed at 378C with a Cs glutamate pipette solution
containing 10 mM BAPTA (z30 nM free Ca21). CT failed
to enhance the Ca21 current induced by dialysis with
BAPTA, just as it had failed to enhance the thapsigargin-
induced current. The peak current at 280 mV was 230 6
6 pA in control cells (n 5 10) and 228 6 5 pA in cells pre-
treated with CT (n 5 10). These data provide further
evidence that neither CT nor Gs acts directly on the
CRAC channels, and they point to the intervention of CT
at a step upstream of the channel itself.
Phosphoinositide Hydrolysis and Calcium Release
Because the CT target lies upstream of the Ca21 channels,
a logical candidate is the Ca21-releasing messenger, InsP3.
Augmentation of InsP3 formation should enhance ICRAC at
low antigen levels, but as antigen concentration is in-
creased, a point should be reached at which sufficient
InsP3 is generated to completely release the Ca21 stores.
No further effect of CT on ICRAC induction is expected be-
yond this concentration of antigen. In principle, this mech-
anism could explain why CT selectively amplifies antigen-
but not thapsigargin-induced ICRAC, because thapsigargin
releases stored Ca21 independent of phosphoinositide hy-
drolysis. To test this hypothesis we measured antigen-stim-
ulated production of [3H]inositol phosphates (InsPx) in
control cells and cells pretreated for 2 h with 2 mg/ml CT.
InsPx were measured at 200 s after antigen addition, a
time which corresponds to the peak Ca21 current induced
by 5 ng/ml TNP-BSA. As indicated in Fig. 5, at a concen-
tration of TNP-BSA (5 ng/ml) for which CT amplified
the induced current by 220%, CT did not significantly af-
fect hydrolysis of [3H]labeled inositol phospholipids. For
longer preincubations (5–6 h), CT caused a modest en-
hancement of antigen-stimulated InsPx production (Mc-
Closkey, 1988). Thus, it appears that CT does not potenti-
ate ICRAC via enhancement of phosphoinositide hydrolysis.
To further test the hypothesis that CT potentiates ICRAC
by accentuating antigen-induced Ca21 release, we mea-
sured cytosolic free calcium after stimulation of IgE-sensi-
tized RBL-2H3 cells with antigen. Cells were pretreated or
not with 2 mg/ml21 CT for 1 h, loaded with 2 mM fura-2
AM for 30 min, kept for another 30 min at 378C, and then
stimulated with 5 ng/ml21 TNP-BSA on the stage of the
microscope. Cells were plated at the same low density as
during patch clamping, which limited the average number
Figure 4. Dose-response plot for induction of ICRAC by thapsigar-
gin during perforated patch recording at 378C. Black bars are
control cells and gray bars CT-treated cells. Note that pretreat-
ment with CT did not amplify the Ca21 current induced by
thapsigargin at any concentration. This indicates that the open
probability of CRAC channels is not modulated by direct binding
to Gs or toxin molecules. Numbers inside of bars give sample
size. Error bars represent SEM.McCloskey and Zhang Cholera Toxin-enhanced Ca21 Current in Mast Cells 143
per field to z17. Nine control and nine CT-treated mono-
layers were examined over a 5-min period, during which
90.2 6 4.8% of the control and 91.6 6 3.6% of the CT-
treated cells responded to antigen. Resting calcium levels
were the same in the two populations, the fluorescence ra-
tio F340/F380 being 0.18 6 0.02 in control and 0.19 6 0.01 in
CT-treated cells. The average lag between antigen addi-
tion and the initial rise in [Ca21]i was the same in control
(1.92 6 0.25 min) and CT-treated cells (1.80 6 0.11 min),
as was the maximum rate of rise of [Ca21]i (2.28 6 0.15
min21 in control vs. 2.19 6 0.11 min21 in CT-treated cells).
Variability of lag phases was removed by thresholding,
and the initial [Ca21]i peaks were aligned as described in
Materials and Methods. The corresponding plots as shown
in Fig. 6 show no statistically significant difference be-
tween the peak heights or the rate of decline in [Ca21]i in
control and CT-treated cells. By these criteria, it does not
appear that the ability of CT to double antigen-evoked
ICRAC is due to enhanced Ca21 release from internal com-
partments.
Effects of BFA on Ca21 Current
In addition to their cell surface localization, some hetero-
trimeric G proteins, including Gs, are located on intracel-
lular membranes, where they regulate vesicle trafficking
(Helms, 1995). CT enhances transcytosis of vesicles con-
taining the poly Ig receptor as well as the apical transport
of influenza hemagglutinin (Bomsel and Mostov, 1993;
Pimplikar and Simons, 1993). Conceivably, CT affects the
trafficking of vesicles, including those bearing CRAC
channels, to or from the plasma membrane of RBL-2H3
cells. To test this hypothesis, we examined the effects of
BFA on CT-enhanced ICa. BFA is a fungal metabolite that
inhibits certain vesicle transport and fusion steps by inhib-
iting GTP/guanosine diphosphate exchange on ARF pro-
teins, thereby blocking their association with membranes
(Klausner et al., 1992; Randazzo et al., 1993). Cells were
preincubated with BFA, CT, or BFA plus CT for 1.5–3 h,
and voltage-clamp measurements performed after patch
permeabilization. BFA was present throughout the nysta-
tin permeabilization and recording periods. At a concen-
tration (2 mg/ml) that had no significant effect on ICa in-
duced by suboptimal antigen (5 ng/ml TNP-BSA), BFA
reduced by 84% the enhancement of ICa by CT (Fig. 7).
This implicates the involvement of ARF in the enhance-
ment of ICRAC by CT.
We next determined whether BFA reduced the en-
hancement of ICa through blocking the ADP ribosylation
of Gsa, rather than by modulating a function of Gs so
modified. This is an important question because BFA pre-
vents the membrane association of ARF proteins, which
can enhance ADP ribosylation of Gsa in vitro (Kahn and
Gilman, 1986). We examined the effect of BFA on ADP
ribosylation of endogenous Gsa by assaying the CT-medi-
ated [32P]ADP ribosylation of Gs in membrane prepara-
tions. Cells were pretreated with 2 mg/ml CT in the pres-
ence or the absence of 2 mg/ml BFA. Membranes from
control and CT-treated cells were then isolated and
treated with activated CT and 32P-NAD. Fig. 8 shows that
pretreatment of cells with CT (Fig. 8, lane D) prevented
the subsequent transfer of [32P]ADP ribosyl moieties to
Gsa, presumably because the acceptor arginine residue in
Gsa was already substituted with nonradioactive ADP ri-
bose from endogenous NAD. If BFA were to prevent this
reaction in intact cells, then incubation of cells with both
CT and BFA before membrane isolation should cause the
reappearance of a radioactive band in the gel after in vitro
treatment with radioactive NAD and activated CT. How-
ever, as shown in Fig. 8, lanes C and E, the presence of
Figure 5. Antigen-stimulated release of total inositol phosphates
(InsPx) in control and CT-pretreated cells. Cell monolayers were
preincubated for 2 h with MEM 6 2 mg/ml CT, rinsed, and stimu-
lated for 200 s with TNP-BSA at the indicated concentration.
Black, control cells; gray, CT-pretreated cells. CT did not signifi-
cantly affect InsPx production under conditions where antigen-
induced ICRAC was amplified 2.2-fold. For much longer preincu-
bations, modest enhancement was observed. Error bars give
SEM of four to seven experiments, each run in triplicate.
Figure 6. CT does not enhance the rate or extent of antigen-
induced Ca21 release in RBL-2H3 cells. Fluorescence from
fura-2  loaded cells was digitally imaged and the fluorescence ra-
tio (F340/F380) plotted at 4-s intervals. A thresholding routine was
used to align the [Ca21]i peaks from cells on each coverslip. Aver-
ages for nine control (filled circles) and nine CT-treated cover-
slips (filled squares) are shown, representing a total 150 cells for
each treatment. Error bars represent SEM and face downward
for CT-treated cells and upward for control cells.The Journal of Cell Biology, Volume 148, 2000 144
BFA at 2 mg/ml did not interfere with ADP ribosylation
either in vitro (Fig. 8, lane C) or in intact cells (Fig. 8, lane
E). Thus, the inhibition by BFA of CT-enhanced ICRAC is
not an artifact of reduced ADP ribosylation of the CT sub-
strate, Gs.
Could the differential effect of CT at low vs. high anti-
gen levels indicate a progressively greater contribution of
an ARF-mediated event with increase in antigen concen-
tration? At a concentration of TNP-BSA (500 ng/ml) that
induced the maximal Ca21 current, BFA substantially in-
hibited the induction. In these experiments cells were pre-
incubated with 2 mg/ml BFA for 1 h at 378C before patch
clamping, and they were also exposed to the drug during
the permeabilization and induction periods. In measure-
ments performed on 5-d cultures, the magnitude of ICa was
261.7 6 6.6 pA (n 5 12), whereas in BFA-treated cells,
the peak ICa was 245.6 6 4.9 pA (n 5 14). In 4-d cultures,
500 ng/ml TNP-BSA induced ICa of 246.8 6 2.2 pA (n 5
5) in control, and 235.8 6 4.3 pA (n 5 5) in BFA-treated
cells. Thus, BFA inhibited the induction of CRAC cur-
rents z30% for both 4- and 5-d cultures, although at this
sample size the difference is barely significant at P 5 0.05.
In contrast, BFA did not affect ICa induced by thapsigar-
gin. The average current induced by 100 nM thapsigargin
was 238.9 6 5.9 pA (n 5 10) in control cells, and 238.9 6
5.5 pA (n 5 10) in cells pretreated for 1.5–2.5 h with 2 mg/ml
BFA. These findings suggest that the FceRI activates
ICRAC through means in addition to Ca21 store depletion,
and that BFA and CT affect a step unique to the antigen-
induced pathway to ICRAC. But if so, why were the maximal
Ca21 currents induced by thapsigargin and antigen simi-
lar? One clue comes from preliminary experiments on the
effect of thapsigargin added after maximal induction of
ICRAC by antigen. Thapsigargin induced a Ca21 current of
246 6 3 pA (n 5 6) in cells stimulated previously with op-
timal antigen (500 or 5000 ng/ml TNP-BSA), a 44% in-
crease over the initial antigen-induced current in the same
cells, and 21% greater than the thapsigargin-induced cur-
rent in antigen-naive cells. Thus, the antigen-stimulated
cells might contain a greater number of CRAC channels
with a lower open probability than those in thapsigargin-
stimulated cells. The latter would not be surprising, given
that ICRAC in RBL-2H3 cells is desensitized by protein ki-
nase C–dependent phosphorylation (Penner et al., 1986),
and this enzyme could be more active in antigen- than
thapsigargin-treated cells. Moreover, thapsigargin irre-
versibly depletes the Ca21 stores, whereas antigen causes
an oscillatory Ca21 signal that requires InsP3, to which the
InsP3 receptor becomes desensitized.
Discussion
Other than a role for Ca21 store depletion, the molecular
mechanisms that regulate antigen-stimulated Ca21 influx
into mast cells are not well-understood. The observation
that CT dramatically enhances 45Ca21 influx into RBL-
2H3 cells suggests that this reagent might be a useful tool
to study the Ca21 entry pathway (Narasimhan et al., 1988).
That CT amplifies both antigen-evoked ICRAC and 45Ca21
influx to a similar extent bolsters the idea that CRAC
channels are a major pathway for FceRI-mediated Ca21
uptake into RBL-2H3 mast cells (Zhang and McCloskey,
1995).
Two hypotheses to explain the effect of CT on 45Ca21
influx are immediately testable by patch clamping. First, it
is possible that CT activates Cl2 or K1 channels, and
thereby increases the electrical force propelling Ca21 en-
try. This indirect mechanism cannot explain the enhance-
ment of Ca21 influx currents that we observed, because
voltage-clamp measurements eliminate any difference in
membrane potential between control and CT-treated cells.
Second, Gs might bind directly to CRAC channels and
increase their open probability, as occurs with voltage-
Figure 7. BFA inhibits the enhancement of antigen-induced ICa
by CT. Simultaneous treatment with 2 mg/ml BFA and 2 mg/ml
CT blocks by 84% the enhancement of antigen-elicited ICa by
CT, whereas magnitude of Ca21 current induced by suboptimal
antigen alone or by optimal thapsigargin was not affected. Cur-
rents were measured using perforated patch recording at 378C,
using a TNP-BSA concentration of 5 ng/ml and a thapsigargin
concentration of 100 nM. Black bars, control cells; gray bars, cells
treated with BFA. Numbers inside bars give sample size.
Figure 8. BFA does not inhibit ADP ribosylation of endogenous
Gsa subunits by CT. Membranes were isolated from RBL-2H3
cells pretreated or not with 2 mg/ml CT with or without 2 mg/ml
BFA, and then subjected to in vitro ADP ribosylation with acti-
vated CT and 32P-NAD. The presumed Gsa subunits span the
range of Mr from 48.9–53.2 kD. (Lane A) no CT in vitro; (lane B)
control membranes; (lane C) control membranes plus 2 mg/ml
BFA in vitro; (lane D) membranes from cells pretreated with CT;
and (lane E) membranes from cells pretreated with CT and BFA,
and subjected to [32P]ADP ribosylation in vitro in the absence of
BFA. Similar results were obtained in three separate experi-
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dependent Ca21 channels (Hamilton et al., 1991). This
mechanism is no longer tenable, as CT did not affect the
CRAC currents elicited by BAPTA or thapsigargin (at con-
centrations inducing submaximal or maximal ICa). Although
the negative result with BAPTA could be due to loss of crit-
ical cytosolic factors during conventional whole cell record-
ing, this is not true for the induction by thapsigargin during
perforated-patch recording, nor can reduced rates of fast or
slow inactivation explain the amplified ICRAC.
CT by itself does not provide all signals required to acti-
vate ICRAC. Rather, it appears to amplify a signal unique to
the FceRI-initiated pathway for induction of ICRAC, some-
where upstream of the channels themselves. An obvious
candidate for the site of intervention is the formation of
Ca21-releasing second messengers. As shown in Fig. 5, at a
concentration of antigen at which CT enhanced ICRAC by
2.2-fold, CT did not affect antigen-stimulated phospho-
inositide hydrolysis. As observed previously, prolonged in-
cubation (6 h) with CT significantly enhanced inositol
phosphates production, but this preincubation was much
longer than that required for ICRAC enhancement (McClos-
key, 1988). In addition, others have reported that CT does
not affect the FceRI-linked production of inositol-1,4,5-
trisphosphate per se (Narasimhan et al., 1988). In any case,
we found that neither the rate of Ca21 release nor the peak
Ca21 rise was greater in CT-treated than control cells, sug-
gesting that the ability of CT to double antigen-induced
ICRAC is not due to enhanced Ca21 release.
ARF is a monomeric GTPase that interacts with the CT-A
subunit to enhance ADP ribosylation of Gsa (Kahn and
Gilman, 1986). Six members of the ARF family are cur-
rently recognized, each of which reversibly associates with
membranous organelles (Hosaka et al., 1996). In their
GTP-bound state, ARF proteins activate phospholipase D
(Brown et al., 1993; Cockcroft et al., 1994) and promote
the assembly of protein coats that mediate vesicle budding
and transport (for reviews see Donaldson and Klausner,
1994; Boman and Kahn, 1995; Moss and Vaughn, 1998).
ARF binds to both Gs and CT-A in vitro (Boman and
Kahn, 1995; Colombo et al., 1995), and it is possible that
either interaction might perturb ARF function in cellulo.
Together with ARF, Gs is present on the TGN, where it
regulates vesicle budding (for review see Helms, 1995).
These observations suggest that CT might enhance ICRAC
by modulating ARF activity. We tested this idea with
BFA, a fungal metabolite that prevents membrane asso-
ciation of ARF and inhibits ARF-dependent functions
(Klausner et al., 1992). That BFA strongly inhibited the
enhancement of ICRAC by CT, and in preliminary experi-
ments partially inhibited the induction of ICRAC by optimal
antigen, suggests that ARF proteins may participate in the
induction of ICRAC by antigen.
Further studies are necessary to confirm this idea, but it
is tempting to speculate that the FceRI, through means in
addition to Ca21 store depletion, somehow modulates an
ARF function that controls CRAC channel activity. Inter-
estingly, cross-linkage of the FceRI in RBL-2H3 cells in-
hibits redistribution of ARF and b-COP from Golgi
membranes to the cytosol after cell permeabilization (De
Matteis et al., 1993). Cross-linkage of FceRI also in-
creases the rate of vesicular transport of 35S-labeled pro-
teoglycans from distal Golgi compartments to the plasma
membrane, a putative ARF-dependent process (Buccione
et al., 1996).
If CT amplifies a signal linking the FceRI to ARF, how
could this enhance ICRAC? One possibility stems from the
observation that pretreatment of PC12 cells with CT en-
hances the cell-free formation of both constitutive secre-
tory vesicles and immature secretory granules from the
TGN (Leyte et al., 1992). In MDCK epithelial cells, CT
acts via Gs to stimulate transcytosis of occupied poly-Ig re-
ceptors and increase apical transport of vesicles bearing
influenza hemagglutinin (Bomsel and Mostov, 1993; Pim-
plikar and Simons, 1993). Activation of Gs with CT also
inhibits endosome fusion in J774 macrophages, a process
thought to involve ARF (Colombo et al., 1994). The ARF-
directed reagent BFA inhibits so-called constitutive secre-
tion as well as insulin-triggered exocytosis of vesicles bear-
ing the GLUT4 glucose transporter in rat adipocytes
(Lachaal et al., 1994), Ca21-induced exocytosis of secre-
tory granules in melanotrophs (Rupnik et al., 1995),
cAMP-induced delivery of the cystic fibrosis transmem-
brane conductance regulator to the surface of human air-
way epithelial cells (Schwiebert et al., 1994), and recycling
of transferrin receptors to the cell surface of K562 cells
(Schonhorn and Wessling-Resnick, 1994). Further studies
are necessary to determine whether ARF, through vesicle
transport or other means, participates in the induction of
ICRAC via the FceRI.
In summary, the potentiation of ICRAC by CT does not
result from direct modification of CRAC channel proper-
ties by Gs or CT. Nor is it an indirect result of membrane
hyperpolarization or reduced rates of ICRAC inactivation.
The effect is restricted to antigen-induced ICRAC, and the
site of intervention apparently lies upstream of the CRAC
channels themselves. It appears to be independent of
phosphoinositide hydrolysis or the rate of Ca21 release.
Although other interpretations are tenable, the data sug-
gest that FceRI may act via ARF to enhance surface
CRAC channel activity.
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